Incidence and predictors of hyperkalemia in patients with heart failure - An analysis of the candesartan in heart failure - Assessment of reduction in mortality and morbidity (CHARM) program

被引：0
|
作者：
Desai, AS
Swedberg, K
Mcmurray, JJV
Granger, CB
Yusut, S
Young, JB
Dunlap, ME
Solomon, SD
Hainer, JW
Olotsson, B
Michelson, EL
Pfeffer, MA
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Sahlgrens Univ Hosp, Gothenburg, Sweden
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2006年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：52A / 52A
页数：1
相关论文
共 50 条
  • [21] Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy
    Colombo, Giorgio L.
    Caruggi, Mauro
    Ottolini, Chiara
    Maggioni, Aldo P.
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (01) : 223 - 234
  • [22] Resource utilization and costs in the Candesartan in Heart failure:: Assessment of Reduction in Mortality and morbidity (CHARM) programme
    McMurray, John J. V.
    Andersson, Fredrik L.
    Stewart, Simon
    Svensson, Klas
    Solal, Alain Cohen
    Dietz, Rainer
    Vanhaecke, Johan
    van Veldhuisen, Dirk J.
    Östergren, Jan
    Granger, Christopher B.
    Yusuf, Salim
    Pfeffer, Marc A.
    Swedberg, Karl
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (12) : 1447 - 1458
  • [23] Resource Consumption and Cost of Candesartan in the Treatment of Heart Failure: Austrian Results of the CHARM-Programme (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity)
    Fruhwald, Friedrich M.
    Vavrovsky, Anna
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 (17-18) : A59 - A59
  • [24] Weight loss (but not weight gain) is a strong predictor of mortality in chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program
    Kenchaiah, S
    McMurray, JJ
    Pocock, SJ
    Wang, DL
    Solomon, SD
    McEntegart, M
    Michelson, EL
    Granger, CB
    Pfeffer, MA
    [J]. CIRCULATION, 2005, 112 (17) : U660 - U660
  • [25] Initial data supporting the design of the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity (CHARM) programme
    McKelvie, Robert S.
    [J]. JOURNAL OF HYPERTENSION, 2006, 24 : S9 - S13
  • [26] Impact of candesartan in preventing myocardial infarction: Results of the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) programme
    Demers, C
    McMurray, JJ
    Swedberg, K
    McKelvie, RS
    Olofsson, B
    Ostergren, J
    Solomon, S
    Yusuf, S
    [J]. CIRCULATION, 2004, 110 (17) : 514 - 514
  • [27] Candesartan improves functional class across a broad spectrum of patients with chronic heart failure:: Results of the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity programme (CHARM)
    McMurray, JJ
    Östergren, J
    Olofsson, B
    Granger, CB
    Michelson, E
    Young, JB
    Dunlap, M
    Yusuf, S
    Swedberg, K
    Pfeffer, MA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 206A - 206A
  • [28] The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure -: An analysis of the Candesartan in Heart failure:: Assessment of Reduction in Mortality and Morbidity (CHARM) program
    Gerstein, Hertzel C.
    Swedberg, Karl
    Carlsson, Jonas
    McMurray, John J. V.
    Michelson, Eric L.
    Olofsson, Bertil
    Pfeffer, Marc A.
    Yusuf, Salim
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (15) : 1699 - 1704
  • [29] Clinical Characteristics and Outcomes of Young and Very Young Adults With Heart Failure The CHARM Programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity)
    Wong, Chih M.
    Hawkins, Nathaniel M.
    Jhund, Pardeep S.
    MacDonald, Michael R.
    Solomon, Scott D.
    Granger, Christopher B.
    Yusuf, Salim
    Pfeffer, Marc A.
    Swedberg, Karl
    Petrie, Mark C.
    McMurray, John J. V.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (20) : 1845 - 1854
  • [30] Effect of candesartan on New York Heart Association functional class - Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
    O'Meara, E
    Solomon, S
    McMurray, J
    Pfeffer, M
    Yusuf, S
    Michelson, E
    Granger, C
    Olofsson, B
    Young, JB
    Swedberg, K
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (21) : 1920 - 1926
12345